Vacuolar myelopathy in transgenic mice expressing human immunodeficiency virus type 1 proteins under the regulation of the myelin basic protein gene promoter
- 1 June 1996
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 2 (6) , 655-661
- https://doi.org/10.1038/nm0696-655
Abstract
Vacuolar myelopathy is a common neurological complication in AIDS patients. The pathogenesis of this spinal cord white matter disease remains unclear and it is still debated whether infection of spinal cord with the human immunodeficiency virus type 1 (HIV-1) is causing the disease. We have generated transgenic mice expressing the entire HIV-1 genome under the regulation of an oligodendrocyte-specific promoter. These mice develop spinal cord vacuolar lesions similar to those found in AIDS patients. This animal model provides in vivo evidence linking the expression of HIV-1 proteins in oligodendrocytes to the spinal cord damage found in vacuolar myelopathy.Keywords
This publication has 45 references indexed in Scilit:
- Cytokine expression of macrophages in HIV‐1‐associated vacuolar myelopathyNeurology, 1993
- AIDS-MyelopathyPathology - Research and Practice, 1993
- Neuropathology of the spinal cord in the acquired immunodeficiency syndromeHuman Pathology, 1992
- Idiopathic myelopathies with white matter vacuolation in non-acquired immunodeficiency syndrome patientsHuman Pathology, 1991
- Vacuolar Myelopathy in AIDSPathology - Research and Practice, 1990
- Dissociation of AIDS‐related vacuolar myelopathy and productive HIV‐1 infection of the spinal cordNeurology, 1989
- Human Immunodeficiency Virus in Glial Cells, ContinuedThe Journal of Infectious Diseases, 1988
- Human Immunodeficiency Virus in Glial Cells?The Journal of Infectious Diseases, 1988
- Vacuolar Myelopathy Pathologically Resembling Subacute Combined Degeneration in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985
- Spinal cord degeneration in AIDSNeurology, 1985